BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.92% |
| 2 | Financials | 6.08% |
| 3 | Healthcare | 5.28% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Communication Services | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PACW
2676
DELISTED
PacWest Bancorp
PACW
| $174K | ﹤0.01% |
4,629
-8,218
| -64% | -$318K |
|
2677
PJT Partners
PJT
$4.46B
| $173K | ﹤0.01% |
4,150
+4,143
| +59,186% | +$178K |
|
|
QTNA
2678
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $173K | ﹤0.01% |
7,122
+7,113
| +79,033% | +$124K |
|
2679
Televisa
TV
$1.53B
| $173K | ﹤0.01% |
15,663
+13,912
| +795% | +$165K |
|
|
PTR
2680
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $173K | ﹤0.01% |
2,646
+557
| +27% | +$36K |
|
2681
Omeros
OMER
$1.24B
| $172K | ﹤0.01% |
9,923
+9,862
| +16,167% | +$142K |
|
|
VIVO
2682
DELISTED
Meridian Bioscience Inc
VIVO
| $171K | ﹤0.01% |
9,688
+7,258
| +299% | +$121K |
|
|
HT
2683
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $169K | ﹤0.01% |
9,855
+2,223
| +29% | +$40.1K |
|
|
EPZM
2684
DELISTED
Epizyme, Inc
EPZM
| $169K | ﹤0.01% |
13,627
+12,380
| +993% | +$138K |
|
2685
VanEck Indonesia Index ETF
IDX
$36.6M
| $168K | ﹤0.01% |
7,448
+2,434
| +49% | +$56K |
|
2686
Marcus Corp
MCS
$925M
| $168K | ﹤0.01% |
4,190
+3,001
| +252% | +$124K |
|
2687
HealthStream
HSTM
$846M
| $168K | ﹤0.01% |
5,971
+5,384
| +917% | +$141K |
|
|
WW
2688
DELISTED
WW International
WW
| $168K | ﹤0.01% |
8,313
+6,708
| +418% | +$185K |
|
2689
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$723M
| $167K | ﹤0.01% |
3,810
-3,215
| -46% | -$143K |
|
2690
Enphase Energy
ENPH
$5.35B
| $166K | ﹤0.01% |
18,003
-30,098
| -63% | -$229K |
|
2691
iShares MSCI Singapore ETF
EWS
$1.17B
| $166K | ﹤0.01% |
7,000
| – | – |
|
|
IPHS
2692
DELISTED
Innophos Holdings, Inc.
IPHS
| $166K | ﹤0.01% |
5,504
+2,570
| +88% | +$77.1K |
|
2693
Encore Capital Group
ECPG
$2.2B
| $166K | ﹤0.01% |
6,078
+3,788
| +165% | +$113K |
|
2694
Logitech
LOGI
$14.8B
| $165K | ﹤0.01% |
+4,200
| New | +$151K |
|
|
CBAY
2695
DELISTED
Cymabay Therapeutics
CBAY
| $165K | ﹤0.01% |
+12,434
| New | +$132K |
|
|
TRTX
2696
TPG RE Finance Trust
TRTX
$609M
| $165K | ﹤0.01% |
8,418
+5,441
| +183% | +$107K |
|
2697
Unitil
UTL
$995M
| $165K | ﹤0.01% |
3,037
+2,013
| +197% | +$105K |
|
2698
Hamilton Lane
HLNE
$5.74B
| $164K | ﹤0.01% |
3,762
+3,479
| +1,229% | +$143K |
|
|
DRNA
2699
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $164K | ﹤0.01% |
+11,177
| New | +$128K |
|
2700
Wave Life Sciences
WVE
$1.07B
| $164K | ﹤0.01% |
4,210
+4,206
| +105,150% | +$171K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.